Business
The ASX health giant riding COVID’s second wave – The Australian Financial Review
Fisher & Paykel Healthcare’s humidifiers have become vital to the treatment of COVID-19 cases. But investors are starting to look beyond the virus.
Operating revenue surged 59 per cent to $NZ910.2 million ($862.7 million) as earnings rose 86 per cent to $NZ225.5 million ($213.7 million).
Typically, the group has derived about 60 per cent of its revenue from selling hardware and associated consumables into hospitals, with the other 40 per cent from selling products for home care, particularly in the treatment of sleep apnoea.
But in the September half, 75 per cent of revenue came from the hospital side of the business. Hospital hardware sales…
-
Noosa News24 hours agoRenewed financial threat for Star Entertainment as Brisbane casino deal faces collapse
-
Noosa News22 hours agoBlues, Booze & BBQs at MANIAX Newstead: All the Details
-
Noosa News23 hours agoCritical infrastructure funding will bring 20,000 homes to 3 Brisbane suburbs
-
Business23 hours agoMacquarie initiates coverage of Superloop shares with outperform rating